196 related articles for article (PubMed ID: 19858414)
1. Three-year outcomes after sirolimus-eluting stent implantation for unprotected left main coronary artery disease: insights from the j-Cypher registry.
Toyofuku M; Kimura T; Morimoto T; Hayashi Y; Ueda H; Kawai K; Nozaki Y; Hiramatsu S; Miura A; Yokoi Y; Toyoshima S; Nakashima H; Haze K; Tanaka M; Take S; Saito S; Isshiki T; Mitsudo K;
Circulation; 2009 Nov; 120(19):1866-74. PubMed ID: 19858414
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 5-year outcomes in patients with and without unprotected left main coronary artery disease after treatment with sirolimus-eluting stents: insights from the j-Cypher registry.
Toyofuku M; Kimura T; Morimoto T; Hayashi Y; Shiode N; Nishikawa H; Nakao K; Shirota K; Kawai K; Hiasa Y; Kadota K; Nozaki Y; Isshiki T; Sone T; Mitsudo K;
JACC Cardiovasc Interv; 2013 Jul; 6(7):654-63. PubMed ID: 23866178
[TBL] [Abstract][Full Text] [Related]
3. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
[TBL] [Abstract][Full Text] [Related]
4. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A;
JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes of sirolimus-eluting stents vs. paclitaxel-eluting stents in unprotected left main coronary artery bifurcation lesions.
Song PS; Ryu DR; Song YB; Hahn JY; Choi JH; Choi SH; Lee SH; Hong KP; Park JE; Gwon HC
Clin Cardiol; 2011 Jun; 34(6):378-83. PubMed ID: 21538383
[TBL] [Abstract][Full Text] [Related]
6. Three-year outcome of sirolimus-eluting stent implantation in coronary bifurcation lesions: the provisional side branch stenting approach versus the elective two-stent approach.
Tamura T; Kimura T; Morimoto T; Nakagawa Y; Furukawa Y; Kadota K; Tatami R; Kawai K; Sone T; Miyazaki S; Mitsudo K;
EuroIntervention; 2011 Sep; 7(5):588-96. PubMed ID: 21930463
[TBL] [Abstract][Full Text] [Related]
7. Sirolimus-eluting stent implantation for ostial left anterior descending coronary artery lesions: three-year outcome from the j-Cypher Registry.
Kishi K; Kimura T; Morimoto T; Namura M; Muramatsu T; Nishikawa H; Hiasa Y; Isshiki T; Nobuyoshi M; Mitsudo K;
Circ Cardiovasc Interv; 2011 Aug; 4(4):362-70. PubMed ID: 21712527
[TBL] [Abstract][Full Text] [Related]
8. Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry.
Kimura T; Morimoto T; Nakagawa Y; Kawai K; Miyazaki S; Muramatsu T; Shiode N; Namura M; Sone T; Oshima S; Nishikawa H; Hiasa Y; Hayashi Y; Nobuyoshi M; Mitudo K;
Circulation; 2012 Jan; 125(4):584-91. PubMed ID: 22203694
[TBL] [Abstract][Full Text] [Related]
9. First generation versus new generation drug-eluting stents for the treatment of ostial/midshaft lesions in unprotected left main coronary artery: the Milan and New-Tokyo (MITO) registry.
Naganuma T; Chieffo A; Takagi K; Panoulas VF; Mitomo S; Sticchi A; Latib A; Miyazaki T; Sato K; Costopoulos C; Fujino Y; Montorfano M; Carlino M; Nakamura S; Colombo A
Catheter Cardiovasc Interv; 2015 Feb; 85(3):E63-9. PubMed ID: 25099758
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
Mehilli J; Kastrati A; Byrne RA; Bruskina O; Iijima R; Schulz S; Pache J; Seyfarth M; Massberg S; Laugwitz KL; Dirschinger J; Schömig A;
J Am Coll Cardiol; 2009 May; 53(19):1760-8. PubMed ID: 19422982
[TBL] [Abstract][Full Text] [Related]
11. Impact of interventional strategy for unprotected left main coronary artery percutaneous coronary intervention on long-term survival.
Lehmann R; Ehrlich JR; De Rosa S; Spyridopoulos I; Laskowski R; Kremer J; Herrmann E; Zeiher AM; Schächinger V; Fichtlscherer S
Can J Cardiol; 2012; 28(5):553-60. PubMed ID: 22554579
[TBL] [Abstract][Full Text] [Related]
12. Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with drug-eluting stents in patients with myocardial infarction.
Lee MS; Sillano D; Latib A; Chieffo A; Zoccai GB; Bhatia R; Sheiban I; Colombo A; Tobis J
Catheter Cardiovasc Interv; 2009 Jan; 73(1):15-21. PubMed ID: 19089930
[TBL] [Abstract][Full Text] [Related]
13. Long-term clinical outcomes after drug-eluting stent implantation in unprotected left main coronary artery disease.
Tamburino C; Angiolillo DJ; Capranzano P; Di Salvo M; Ussia G; La Manna A; Guzman LA; Galassi AR; Bass TA
Catheter Cardiovasc Interv; 2009 Feb; 73(3):291-8. PubMed ID: 19214963
[TBL] [Abstract][Full Text] [Related]
14. Randomized comparison of coronary bifurcation stenting with the crush versus the culotte technique using sirolimus eluting stents: the Nordic stent technique study.
Erglis A; Kumsars I; Niemelä M; Kervinen K; Maeng M; Lassen JF; Gunnes P; Stavnes S; Jensen JS; Galløe A; Narbute I; Sondore D; Mäkikallio T; Ylitalo K; Christiansen EH; Ravkilde J; Steigen TK; Mannsverk J; Thayssen P; Hansen KN; Syvänne M; Helqvist S; Kjell N; Wiseth R; Aarøe J; Puhakka M; Thuesen L;
Circ Cardiovasc Interv; 2009 Feb; 2(1):27-34. PubMed ID: 20031690
[TBL] [Abstract][Full Text] [Related]
15. Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: the sirolimus vs paclitaxel drug-eluting stent for left main registry (SP-DELFT).
Meliga E; Garcia-Garcia HM; Valgimigli M; Chieffo A; Biondi-Zoccai G; Maree AO; Gonzalo N; Cook S; Marra S; Moretti C; De Servi S; Palacios IF; Windecker S; van Domburg R; Colombo A; Sheiban I; Serruys PW
Int J Cardiol; 2009 Sep; 137(1):16-21. PubMed ID: 18687481
[TBL] [Abstract][Full Text] [Related]
16. Randomized study of the crush technique versus provisional side-branch stenting in true coronary bifurcations: the CACTUS (Coronary Bifurcations: Application of the Crushing Technique Using Sirolimus-Eluting Stents) Study.
Colombo A; Bramucci E; Saccà S; Violini R; Lettieri C; Zanini R; Sheiban I; Paloscia L; Grube E; Schofer J; Bolognese L; Orlandi M; Niccoli G; Latib A; Airoldi F
Circulation; 2009 Jan; 119(1):71-8. PubMed ID: 19103990
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes of elective drug-eluting stenting of the unprotected left main coronary artery in patients with normal left ventricular function.
Lee MS; Yang T; Biondi-Zoccai G; Sillano D; Cerrato E; Tarantini G; Xhaxho J; Aragon J; Sheiban I
Catheter Cardiovasc Interv; 2011 Jun; 77(7):945-51. PubMed ID: 20824773
[TBL] [Abstract][Full Text] [Related]
18. Comparison of outcomes using the sirolimus-eluting stent in calcified versus non-calcified native coronary lesions in patients on- versus not on-chronic hemodialysis (from the j-Cypher registry).
Nishida K; Kimura T; Kawai K; Miyano I; Nakaoka Y; Yamamoto S; Kaname N; Seki S; Kubokawa S; Fukatani M; Hamashige N; Morimoto T; Mitsudo K;
Am J Cardiol; 2013 Sep; 112(5):647-55. PubMed ID: 23707041
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome after crush versus culotte stenting of coronary artery bifurcation lesions: the Nordic Stent Technique Study 36-month follow-up results.
Kervinen K; Niemelä M; Romppanen H; Erglis A; Kumsars I; Maeng M; Holm NR; Lassen JF; Gunnes P; Stavnes S; Jensen JS; Galløe A; Narbute I; Sondore D; Christiansen EH; Ravkilde J; Steigen TK; Mannsverk J; Thayssen P; Hansen KN; Helqvist S; Vikman S; Wiseth R; Aarøe J; Jokelainen J; Thuesen L;
JACC Cardiovasc Interv; 2013 Nov; 6(11):1160-5. PubMed ID: 24262616
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Outcomes of Different Two-Stent Techniques With Second-Generation Drug-Eluting Stents for Unprotected Left Main Bifurcation Disease: Insights From the FAILS-2 Study.
Pavani M; Conrotto F; Cerrato E; D'Ascenzo F; Kawamoto H; Núñez-Gil IJ; Pennone M; Garbo R; Tomassini F; Colombo F; Scacciatella P; Varbella F; Chieffo A; Colombo A; Escaned J
J Invasive Cardiol; 2018 Aug; 30(8):276-281. PubMed ID: 30068784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
